Report cover image

Middle East and Africa Pharmaceuticals Market, By Product Type (Prescription Drugs, Over the Counter (OTC) Drugs, Generic Drugs, Branded Drugs, Biopharmaceuticals); By Therapeutic Area (Cardiology, Oncology, Neurology, Infectious Diseases, Respiratory, Ot

Publisher BlueWeave Consulting
Published Dec 05, 2024
Length 280 Pages
SKU # BLWC19478114

Description

Middle East and Africa Pharmaceuticals Market, By Product Type (Prescription Drugs, Over the Counter (OTC) Drugs, Generic Drugs, Branded Drugs, Biopharmaceuticals); By Therapeutic Area (Cardiology, Oncology, Neurology, Infectious Diseases, Respiratory, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Wholesale/Distributors); By End User (Hospitals & Clinics, Retail Consumers, Academic & Research Institutes, Contract Manufacturing Organizations (CMOs)); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of Middle East & Africa), Trend Analysis, Competitive Landscape & Forecast, 2019–2030


Middle East and Africa Pharmaceuticals Market Size Set to Surpass USD 75 Billion by 2030

Middle East and Africa Pharmaceuticals Market is thriving due to rising incidences of chronic diseases, increasing investments in healthcare, a spurring demand for generic drugs, thriving medical tourism, regulatory support, and R&D initiatives.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Middle East and Africa Pharmaceuticals Market size by value at USD 49.6 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Middle East and Africa Pharmaceuticals Market size to expand at a CAGR of 6.80% reaching a value of USD 75.3 billion by 2030. Middle East and Africa Pharmaceuticals Market is driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and growing demand for advanced medical treatments. Population growth, urbanization, and a rising middle class are also key drivers, along with improving healthcare infrastructure. Additionally, government initiatives to enhance healthcare access and the adoption of innovative drug development technologies contribute to market growth. Increasing focus on personalized medicine and biotechnology further fuels the market's expansion.

Opportunity-Governments’ Initiatives and Healthcare Reforms

Governments’ supportive initiatives and healthcare reforms are projected to significantly drive Middle East and Africa Pharmaceuticals Market. Increasing investments in healthcare infrastructure, coupled with policies to enhance access to essential medicines, are improving healthcare delivery. Governments are also focusing on regulatory improvements, funding local pharmaceutical production, and fostering public-private partnerships, which contribute to the expansion of the pharmaceutical sector. These efforts help reduce reliance on imports and promote the growth of regional pharmaceutical companies.

Impact of Escalating Geopolitical Tensions on Middle East and Africa Pharmaceuticals Market

Escalating geopolitical tensions in the Middle East could disrupt supply chains, causing shortages of raw materials and finished products. It may lead to increased costs, production delays, and hindered access to essential medications. Political instabilities and conflicts could also result in reduced investments, regulatory uncertainties, and restricted market access, further complicating healthcare delivery. However, an increasing demand for healthcare services due to instabilities could drive Middle East and Africa Pharmaceuticals Market.

Hospitals and Clinics Segment Leads MEA Pharmaceuticals Market

Hospitals and clinics are the largest end users in Middle East and Africa Pharmaceuticals Market. Their dominance is driven by the region's expanding healthcare infrastructure, increasing prevalence of chronic and infectious diseases, and rising investments in healthcare services. Hospitals and clinics serve as primary points of care, particularly for prescription medications and advanced treatments. Additionally, government initiatives to improve healthcare access and the growth of private healthcare providers contribute significantly to the segment's leading position.

Competitive Landscape

Middle East and Africa Pharmaceuticals Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Sanofi, Novartis, Pfizer, Merck, Roche, AstraZeneca, Johnson & Johnson, Bayer, Takeda Pharmaceutical Company Limited, and AbbVie. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Middle East and Africa Pharmaceuticals Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Middle East and Africa Pharmaceuticals Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Middle East and Africa Pharmaceuticals Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

280 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Middle East and Africa Pharmaceuticals Market Insights
3.1. Industry Value Chain Analysis
3.1.1. DROC Analysis
3.1.2. Growth Drivers
3.1.2.1. Rising Geriatric Population
3.1.2.2. Prevalence of Chronic Diseases
3.1.2.3. Advancements in Biotechnology and Medical Research
3.1.3. Restraints
3.1.3.1. Intense Competition
3.1.3.2. Strict Regulatory Environment
3.1.4. Opportunities
3.1.4.1. Emerging Markets
3.1.4.2. Government Initiatives and Healthcare Reforms
3.1.5. Challenges
3.1.5.1. High Research and Development Costs
3.1.5.2. Price Controls and Reimbursement Challenges
3.2. Technological Advancements/Recent Developments
3.3. Regulatory Framework
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrants
3.4.4. Threat of Substitutes
3.4.5. Intensity of Rivalry
4. Middle East and Africa Pharmaceuticals Market: Marketing Strategies
5. Middle East and Africa Pharmaceuticals Market Overview
5.1. Market Size & Forecast, 2019–2030
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product Type
5.2.1.1. Prescription Drugs
5.2.1.2. Over the Counter (OTC) Drugs
5.2.1.3. Generic Drugs
5.2.1.4. Branded Drugs
5.2.1.5. Biopharmaceuticals
5.2.2. By Therapeutic Area
5.2.2.1. Cardiology
5.2.2.2. Oncology
5.2.2.3. Neurology
5.2.2.4. Infectious Diseases
5.2.2.5. Respiratory
5.2.2.6. Others
5.2.3. By Distribution Channel
5.2.3.1. Hospital Pharmacies
5.2.3.2. Retail Pharmacies
5.2.3.3. Online Pharmacies
5.2.3.4. Wholesale/Distributors
5.2.4. By End User
5.2.4.1. Hospitals & Clinics
5.2.4.2. Retail Consumers
5.2.4.3. Academic & Research Institutes
5.2.4.4. Contract Manufacturing Organizations (CMOs)
5.2.5. By Country
5.2.5.1. Saudi Arabia
5.2.5.2. UAE
5.2.5.3. Qatar
5.2.5.4. Kuwait
5.2.5.5. South Africa
5.2.5.6. Nigeria
5.2.5.7. Algeria
5.2.5.8. Rest of Middle East and Africa
6. Saudi Arabia Pharmaceuticals Market
6.1. Market Size & Forecast, 2019–2030
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Therapeutic Area
6.2.3. By Distribution Channel
6.2.4. By End User
7. UAE Pharmaceuticals Market
7.1. Market Size & Forecast, 2019–2030
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Therapeutic Area
7.2.3. By Distribution Channel
7.2.4. By End User
8. Qatar Pharmaceuticals Market
8.1. Market Size & Forecast, 2019–2030
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Therapeutic Area
8.2.3. By Distribution Channel
8.2.4. By End User
9. Kuwait Pharmaceuticals Market
9.1. Market Size & Forecast, 2019–2030
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Therapeutic Area
9.2.3. By Distribution Channel
9.2.4. By End User
10. South Africa Pharmaceuticals Market
10.1. Market Size & Forecast, 2019–2030
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Therapeutic Area
10.2.3. By Distribution Channel
10.2.4. By End User
11. Nigeria Pharmaceuticals Market
11.1. Market Size & Forecast, 2019–2030
11.1.1. By Value (USD Million)
11.2. Market Share & Forecast
11.2.1. By Product Type
11.2.2. By Therapeutic Area
11.2.3. By Distribution Channel
11.2.4. By End User
12. Algeria Pharmaceuticals Market
12.1. Market Size & Forecast, 2019–2030
12.1.1. By Value (USD Million)
12.2. Market Share & Forecast
12.2.1. By Product Type
12.2.2. By Therapeutic Area
12.2.3. By Distribution Channel
12.2.4. By End User
13. Rest of MEA Pharmaceuticals Market
13.1. Market Size & Forecast, 2019–2030
13.1.1. By Value (USD Million)
13.2. Market Share & Forecast
13.2.1. By Product Type
13.2.2. By Therapeutic Area
13.2.3. By Distribution Channel
13.2.4. By End User
14. Competitive Landscape
14.1. List of Key Players and Their Offerings
14.2. Middle East and Africa Pharmaceuticals Company Market Share Analysis, 2023
14.3. Competitive Benchmarking, By Operating Parameters
14.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
15. Impact of Escalating Geopolitical Tensions on Middle East and Africa Pharmaceuticals Market
16. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
16.1. Sanofi
16.2. Novartis
16.3. Pfizer
16.4. Merck
16.5. Roche
16.6. AstraZeneca
16.7. Johnson & Johnson
16.8. Bayer
16.9. Takeda Pharmaceutical Company Limited
16.10. AbbVie
16.11. Other Prominent Players
17. Key Strategic Recommendations
18. Research Methodology
18.1. Qualitative Research
18.1.1. Primary & Secondary Research
18.2. Quantitative Research
18.3. Market Breakdown & Data Triangulation
18.3.1. Secondary Research
18.3.2. Primary Research
18.4. Breakdown of Primary Research Respondents, By Region
18.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures
Figure 1 Middle East and Africa Pharmaceuticals Segmentation
Figure 2 Middle East and Africa Pharmaceuticals Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 Middle East and Africa Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Figure 5 Middle East and Africa Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030
Figure 6 Middle East and Africa Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030
Figure 7 Middle East and Africa Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030
Figure 8 Middle East and Africa Pharmaceuticals Market Share, By End User, By Value, 2019–2030
Figure 9 Middle East and Africa Pharmaceuticals Market Share, By Country, By Value, 2019–2030
Figure 10 Saudi Arabia Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Figure 11 Saudi Arabia Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030
Figure 12 Saudi Arabia Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030
Figure 13 Saudi Arabia Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030
Figure 14 Saudi Arabia Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030
Figure 15 UAE Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Figure 16 UAE Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030
Figure 17 UAE Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030
Figure 18 UAE Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030
Figure 19 UAE Pharmaceuticals Market Share, By End User, By Value, 2019–2030
Figure 20 Qatar Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Figure 21 Qatar Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030
Figure 22 Qatar Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030
Figure 23 Qatar Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030
Figure 24 Qatar Pharmaceuticals Market Share, By End User, By Value, 2019–2030
Figure 25 Kuwait Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Figure 26 Kuwait Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030
Figure 27 Kuwait Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030
Figure 28 Kuwait Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030
Figure 29 Kuwait Pharmaceuticals Market Share, By End User, By Value, 2019–2030
Figure 30 South Africa Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Figure 31 South Africa Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030
Figure 32 South Africa Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030
Figure 33 South Africa Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030
Figure 34 South Africa Pharmaceuticals Market Share, By End User, By Value, 2019–2030
Figure 35 Nigeria Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Figure 36 Nigeria Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030
Figure 37 Nigeria Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030
Figure 38 Nigeria Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030
Figure 39 Nigeria Pharmaceuticals Market Share, By End User, By Value, 2019–2030
Figure 40 Algeria Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Figure 41 Algeria Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030
Figure 42 Algeria Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030
Figure 43 Algeria Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030
Figure 44 Algeria Pharmaceuticals Market Share, By End User, By Value, 2019–2030
Figure 45 Rest of MEA Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Figure 46 Rest of MEA Pharmaceuticals Market Share, By Product Type, By Value, 2019–2030
Figure 47 Rest of MEA Pharmaceuticals Market Share, By Therapeutic Area, By Value, 2019–2030
Figure 48 Rest of MEA Pharmaceuticals Market Share, By Distribution Channel, By Value, 2019–2030
Figure 49 Rest of MEA Pharmaceuticals Market Share, By End User, By Value, 2019–2030
List of Tables
Table 1 Middle East and Africa Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Table 2 Middle East and Africa Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030
Table 3 Middle East and Africa Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030
Table 4 Middle East and Africa Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030
Table 5 Middle East and Africa Pharmaceuticals Market Size, By End User, By Value, 2019–2030
Table 6 Middle East and Africa Pharmaceuticals Market Size, By Country, By Value, 2019–2030
Table 7 Saudi Arabia Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Table 8 Saudi Arabia Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030
Table 9 Saudi Arabia Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030
Table 10 Saudi Arabia Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030
Table 11 Saudi Arabia Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030
Table 12 UAE Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Table 13 UAE Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030
Table 14 UAE Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030
Table 15 UAE Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030
Table 16 UAE Pharmaceuticals Market Size, By End User, By Value, 2019–2030
Table 17 Qatar Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Table 18 Qatar Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030
Table 19 Qatar Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030
Table 20 Qatar Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030
Table 21 Qatar Pharmaceuticals Market Size, By End User, By Value, 2019–2030
Table 22 Kuwait Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Table 23 Kuwait Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030
Table 24 Kuwait Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030
Table 25 Kuwait Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030
Table 26 Kuwait Pharmaceuticals Market Size, By End User, By Value, 2019–2030
Table 27 South Africa Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Table 28 South Africa Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030
Table 29 South Africa Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030
Table 30 South Africa Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030
Table 31 South Africa Pharmaceuticals Market Size, By End User, By Value, 2019–2030
Table 32 Nigeria Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Table 33 Nigeria Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030
Table 34 Nigeria Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030
Table 35 Nigeria Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030
Table 36 Nigeria Pharmaceuticals Market Size, By End User, By Value, 2019–2030
Table 37 Algeria Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Table 38 Algeria Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030
Table 39 Algeria Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030
Table 40 Algeria Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030
Table 41 Algeria Pharmaceuticals Market Size, By End User, By Value, 2019–2030
Table 42 Rest of MEA Pharmaceuticals Market Size, By Value (USD Million), 2019–2030
Table 43 Rest of MEA Pharmaceuticals Market Size, By Product Type, By Value, 2019–2030
Table 44 Rest of MEA Pharmaceuticals Market Size, By Therapeutic Area, By Value, 2019–2030
Table 45 Rest of MEA Pharmaceuticals Market Size, By Distribution Channel, By Value, 2019–2030
Table 46 Rest of MEA Pharmaceuticals Market Size, By End User, By Value, 2019–2030
Table 47 Sanofi Company Overview
Table 48 Sanofi Financial Overview
Table 49 Novartis Company Overview
Table 50 Novartis Financial Overview
Table 51 Pfizer Company Overview
Table 52 Pfizer Financial Overview
Table 53 Merck Company Overview
Table 54 Merck Financial Overview
Table 55 Roche Company Overview
Table 56 Roche Financial Overview
Table 57 AstraZeneca Company Overview
Table 58 AstraZeneca Financial Overview
Table 59 Johnson & Johnson Company Overview
Table 60 Johnson & Johnson Financial Overview
Table 61 Bayer Company Overview
Table 62 Bayer Financial Overview
Table 63 Takeda Pharmaceutical Company Limited Company Overview
Table 64 Takeda Pharmaceutical Company Limited Financial Overview
Table 65 AbbVie Company Overview
Table 66 AbbVie Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us